Colon cancer blood test offers new screening option
Time:2024-06-03 17:17:33 Source:worldViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Rugby star and ALS campaigner Rob Burrow dies at age 41
Next:German police officer dies of wounds suffered in knife attack
You may also like
- Sojourner Truth statue unveiled at site of 'Ain't I a Woman?' speech
- Pic Story of Former Serf of Manor in Xizang
- Pic Story of Post
- Pic Story of Sanitation Worker as NPC Deputy
- Trump responds to guilty verdict by falsely blasting 'rigged trial'
- Feature: A Tibetan Woman's Quest to Predict Quakes
- Avid Reader Restores Ancient Books in Shenyang, NE China
- Special School Teacher Educates Minds and More of Hospitalized Students
- Give free passports to Britain's heroes: On the eve of D